Stay updated on Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial
Sign up to get notified when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.

Latest updates to the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page
- Check3 days agoChange Detected- The page revision was updated from v3.3.3 to v3.3.4. No substantive changes to study details or related information.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe Study Locations section was expanded to include multiple U.S. states (Arizona, Arkansas, California, Connecticut, Florida, Indiana, Kansas, Nebraska, Nevada, New Hampshire, New Jersey, New York, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Wisconsin) and a new revision tag (v3.3.3).SummaryDifference2%

- Check53 days agoChange DetectedRevision tag updated to v3.3.2, replacing the previous v3.2.0.SummaryDifference0.0%

- Check60 days agoChange DetectedRemoval of the site-wide government funding notice that warned information may not be up to date. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check75 days agoChange DetectedNo significant content changes detected; only minor formatting or display adjustments appear without altering core study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check103 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

Stay in the know with updates to Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.